Diverse Landscape of Genetically Engineered Mouse Models: Genomic and Molecular Insights into Prostate Cancer
Prostate cancer (PCa) is a significant health concern for men worldwide and is particularly
prevalent in the United States. It is a complex disease presenting different molecular …
prevalent in the United States. It is a complex disease presenting different molecular …
[HTML][HTML] Treatment strategies for high-risk localized and locally advanced and oligometastatic prostate cancer
T Makino, K Izumi, H Iwamoto, A Mizokami - Cancers, 2021 - mdpi.com
Simple Summary The definitions of locally advanced and oligometastatic prostate cancer
are ambiguous, and there are no standard treatments for these. Although multidisciplinary …
are ambiguous, and there are no standard treatments for these. Although multidisciplinary …
[HTML][HTML] Assessing the impact of positive surgical margins on mortality in patients who underwent robotic radical prostatectomy: 20 years' report from the EAU robotic …
Abstract Background Positive surgical margins (PSMs) are frequent in patients undergoing
radical prostatectomy (RP). The impact of PSMs on cancer-specific (CSM) and overall (OM) …
radical prostatectomy (RP). The impact of PSMs on cancer-specific (CSM) and overall (OM) …
External validation of models for prediction of side-specific extracapsular extension in prostate cancer patients undergoing radical prostatectomy
R Diamand, JB Roche, E Lievore, V Lacetera… - European Urology …, 2023 - Elsevier
Background Predicting the risk of side-specific extracapsular extension (ECE) is essential for
planning nerve-sparing radical prostatectomy (RP) in patients with prostate cancer (PCa) …
planning nerve-sparing radical prostatectomy (RP) in patients with prostate cancer (PCa) …
[HTML][HTML] SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long …
K Rans, B Charlien, A Filip, DH Olivier, H Julie… - BMC cancer, 2022 - Springer
Background Metastasis-directed therapy (MDT) significantly delays the initiation of palliative
androgen deprivation therapy (pADT) in patients with oligorecurrent prostate cancer (PCa) …
androgen deprivation therapy (pADT) in patients with oligorecurrent prostate cancer (PCa) …
[HTML][HTML] Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy
C Cano Garcia, M Wenzel, C Humke, C Wittler… - Medicina, 2023 - mdpi.com
Aim and Objectives: We aimed to test the impact of age on long-term urinary continence (≥
12 months) in patients undergoing robotic-assisted radical prostatectomy. Methods and …
12 months) in patients undergoing robotic-assisted radical prostatectomy. Methods and …
Novel approaches in the systemic management of high-risk prostate cancer
MA Gómez-Aparicio, F López-Campos… - Clinical Genitourinary …, 2023 - Elsevier
Locally advanced prostate cancer comprises approximately 20% of new prostate cancer
diagnoses. For these patients, international guidelines recommend treatment with …
diagnoses. For these patients, international guidelines recommend treatment with …
[HTML][HTML] Deep Learning Model for Real‑time Semantic Segmentation During Intraoperative Robotic Prostatectomy
SG Park, J Park, HR Choi, JH Lee, ST Cho… - European Urology Open …, 2024 - Elsevier
Background and objective Recently, deep learning algorithms, including convolutional
neural networks (CNNs), have shown remarkable progress in medical imaging analysis …
neural networks (CNNs), have shown remarkable progress in medical imaging analysis …
A preoperative scoring system for predicting the extraprostatic extension of prostate cancer following radical prostatectomy using magnetic resonance imaging and …
HW Moon, DH Kim, J Kim, B Kim, SN Oh, JI Choi… - Abdominal …, 2024 - Springer
Purpose We aimed to develop a preoperative prediction model for extraprostatic extension
(EPE) in prostate cancer (PCa) patients following radical prostatectomy (RP) using MRI and …
(EPE) in prostate cancer (PCa) patients following radical prostatectomy (RP) using MRI and …
[HTML][HTML] Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: Differences in biochemical recurrence-free survival after radical …
C Siech, B Hoeh, E Rohlfsen, CC Garcia… - … Oncology: Seminars and …, 2024 - Elsevier
Background To test for differences in organ-confined pathological tumor stage (pT) and
intermediate International Society of Urological Pathologists (ISUP) grade vs. nonorgan …
intermediate International Society of Urological Pathologists (ISUP) grade vs. nonorgan …